Hot Topics in Dry Eye Disease.

Area of Science:

• Ophthalmology
• Ocular Surface Disease
• Tear Film Dynamics

Background:

• Dry eye disease (DED) is a complex ocular surface condition characterized by discomfort, visual disturbances, and tear instability.
• Key pathological drivers of DED include hyperosmolarity and inflammation, creating a detrimental feedback loop.
• These interconnected mechanisms contribute to progressive damage of the ocular surface.

Purpose of the Study:

• To review emerging pharmacological and non-pharmacological therapeutic strategies for managing dry eye disease.
• To highlight advancements in DED treatment driven by a deeper understanding of its pathophysiology.

Main Methods:

• Systematic review of current literature on dry eye disease treatments.
• Analysis of novel therapeutic approaches, both medical and non-medical.
• Focus on treatments targeting specific disease mechanisms.

Main Results:

• New treatment strategies for DED have been developed based on enhanced understanding of disease mechanisms.
• The therapeutic focus has shifted from solely alleviating symptoms to addressing the root causes of DED.
• Inflammation has emerged as a primary target in the management of dry eye disease.

Conclusions:

• Current DED management emphasizes targeting specific pathophysiological pathways.
• Addressing inflammation is a key focus in novel DED treatment strategies.
• This shift promises more effective and targeted interventions for patients with dry eye disease.